Product vigilance research has been identified as a key priority for Medsafe and the Health Research Council of New Zealand. The two agencies have established a Joint Initiative to develop capacity for product vigilance research in New Zealand and to support research that explores opportunities for improving the post-market surveillance and monitoring of therapeutic products in New Zealand. This initiative is jointly funded by Medsafe and the HRC, and managed by a Steering Committee which includes representatives of each funding partner and other relevant organisations.
Applications to this fund have now closed.
For more information relating to this initiative, contact Suzanne Rolfe, Project Coordinator, International Investment Opportunities Fund. DDI: +64 9 303 5085. Email: srolfe@hrc.govt.nz
Previous Funding results
Medsafe and the HRC have established a Joint Initiative through the HRC's Partnership Programme to develop capacity for product vigilance research in New Zealand, and to support research that explores opportunities for improving the post-market surveillance and monitoring of therapeutic products in New Zealand.
In December 2008, a Request for Proposals was released to purchase a product vigilance study. Details of funding approved by Medsafe and the HRC Board and offered to the successful research team are listed below.
Product Vigilance - Developing an Integrated System
36 months, $1,000,000
Dr Michael Tatley, Dr Patrick Graham, Dr Tristram Ingham, Dr Lianne Parkin, Professor Charlotte Paul, Mrs Janelle Ashton, Associate Professor Peter Herbison, Dr Alec Holt, Dr Ruth Savage, Dr Brendon Woodford
University of Otago, Christchurch
New Zealand's approach to product vigilance must evolve to keep pace with changing technologies and the international regulatory environment. The proposed programme integrates and extends NZ's product vigilance capability to deliver an interdisciplinary product vigilance research system. The overall aim is to develop a world-class integrated approach to product vigilance to enable timely identification and investigation of potential medicine safety issues of national and international importance.
For more information relating to this initiative, contact Suzanne Rolfe, Project Coordinator, International Investment Opportunities Fund. DDI: +64 9 303 5085. Email: srolfe@hrc.govt.nz
Last Updated : 05 October 2009 11:04:24.
No unsolicited electronic messages to be sent to email addresses on this page.
